Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 71288-115

4 FDA label images from Meitheal Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 71288-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Aza03 0003 01)

Structural Formula (Aza03 0003 01)
Chemical structure of azacitidine depicted as a molecular diagram showing its constituent atoms and bonds. The structure illustrates key functional groups consistent with azacitidine's chemical identity.*
FDA Label Image

Figure (Aza03 0003 02)

Figure (Aza03 0003 02)
A Kaplan-Meier survival curve chart comparing the proportion surviving over time (months) from randomization for Azacitidine (AZA) and a comparator labeled CCR. The chart shows survival probability on the y-axis against time in months on the x-axis, with survival data and number at risk tables below the graph. Statistical results including log-rank p-value, hazard ratio (HR), and death counts for AZA and CCR are displayed on the upper right.*
FDA Label Image

Figure (Aza03 0003 03)

Figure (Aza03 0003 03)
Azacitidine for Injection 100 mg per vial label from Meitheal Pharmaceuticals Inc. The label indicates the product is for subcutaneous and intravenous use only. It is a single-dose vial containing 100 mg of azacitidine and 100 mg mannitol. The label includes cautions, storage instructions, and barcode, and specifies the drug is a cytotoxic agent.*
FDA Label Image

Figure (Aza03 0003 04)

Figure (Aza03 0003 04)
Azacitidine 100 mg per vial injection powder, lyophilized for solution, carton packaging label from Meitheal Pharmaceuticals Inc. The label states it is for subcutaneous and intravenous use, single-dose vial, and includes a caution for cytotoxic agent. Storage instructions and proprietary name are shown, along with barcodes and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.